2-MERCAPTOTHIAZOLINE
General Information
Mainterm | 2-MERCAPTOTHIAZOLINE |
CAS Reg.No.(or other ID) | 96-53-7 |
Regnum |
177.2600 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 2723699 |
IUPAC Name | 1,3-thiazolidine-2-thione |
InChI | InChI=1S/C3H5NS2/c5-3-4-1-2-6-3/h1-2H2,(H,4,5) |
InChI Key | WGJCBBASTRWVJL-UHFFFAOYSA-N |
Canonical SMILES | C1CSC(=S)N1 |
Molecular Formula | C3H5NS2 |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 119.2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 0 |
Complexity | 71.2 |
CACTVS Substructure Key Fingerprint | A A A D c Y B C A A B g A A A A A A A A A A A A A A A A A W A A A A A A A A A A A A A A A A A A A A A A H A Q Q A A A A A A D F Q A S A A A L A A A g E A A A A A A A A A A B A A B k A A I A I A A A A A A A A A A A A A A A A E A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 69.4 |
Monoisotopic Mass | 118.986 |
Exact Mass | 118.986 |
XLogP3 | None |
XLogP3-AA | 0.9 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 6 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9888 |
Human Intestinal Absorption | HIA+ | 0.9459 |
Caco-2 Permeability | Caco2+ | 0.5290 |
P-glycoprotein Substrate | Non-substrate | 0.7362 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9107 |
Non-inhibitor | 0.9803 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.5586 |
Distribution | ||
Subcellular localization | Lysosome | 0.8218 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8826 |
CYP450 2D6 Substrate | Non-substrate | 0.7010 |
CYP450 3A4 Substrate | Non-substrate | 0.7595 |
CYP450 1A2 Inhibitor | Inhibitor | 0.8470 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8042 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.6357 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.5202 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9600 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.6639 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9200 |
Non-inhibitor | 0.9495 | |
AMES Toxicity | AMES toxic | 0.7112 |
Carcinogens | Non-carcinogens | 0.9418 |
Fish Toxicity | Low FHMT | 0.7396 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.7200 |
Honey Bee Toxicity | High HBT | 0.6065 |
Biodegradation | Not ready biodegradable | 0.8584 |
Acute Oral Toxicity | II | 0.7255 |
Carcinogenicity (Three-class) | Danger | 0.4913 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -0.9481 | LogS |
Caco-2 Permeability | 1.5898 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.6304 | LD50, mol/kg |
Fish Toxicity | 2.5464 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.4501 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organoheterocyclic compounds |
Class | Azolidines |
Subclass | Thiazolidines |
Intermediate Tree Nodes | Not available |
Direct Parent | Thiazolidinethiones |
Alternative Parents | |
Molecular Framework | Aliphatic heteromonocyclic compounds |
Substituents | Thiazolidinethione - Cyclic dithiocarbamic acid ester - Dithiocarbamic acid ester - Azacycle - Organic nitrogen compound - Organopnictogen compound - Hydrocarbon derivative - Organosulfur compound - Organonitrogen compound - Aliphatic heteromonocyclic compound |
Description | This compound belongs to the class of organic compounds known as thiazolidinethiones. These are heterocyclic compounds containing a thiazolidinethione ring which bears one thioketone group. |
From ClassyFire